Benno Therapeutics Wins Prestigious Innovation Award at BioFit in Lille
Benno Therapeutics, a Belgian biotech company, has won the award for Most Innovative Animal Health Project at the international BioFit conference in Lille last week. The winning project involves a groundbreaking treatment for bladder cancer dogs.
The award is a significant recognition, as the jury comprised leading companies in the animal health sector. Their appreciation highlights the unique value of the technology and its potential to improve the standard of care for pets worldwide.
"This award means so much to our team," said Erwin Blomsma, CEO of Benno Therapeutics. "We are proud that our young company, founded on February 29 this year, is already being recognized by the top players in the industry."
"It is an incredible honor to receive this award," said Annelies Bogaerts, Chief Development Officer at Benno Therapeutics. "This recognition by the absolute leaders in veterinary medicine confirms the impact our innovation can have. It motivates our team to continue developing solutions that truly improve the lives of animals."
Next to Knowledge for Growth, BioFit is one of Europe’s most important events for innovation and collaboration in healthcare and biotech. The prestigious award underscores Benno Therapeutics' commitment to translating scientific breakthroughs into impactful practical applications.